GlassScriptPhysician profile
Matthew Cavagnaro
NPI 1841424439
$10,454.55
in general payments reported to CMS, 2019-2025
11 companies · $510 in 2025
The $510 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
See the full distribution for Sports Medicine (Orthopaedic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,927 · 2020: $1,719 · 2021: $333 · 2022: $1,582 · 2023: $1,636 · 2024: $1,748 · 2025: $510.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,439 · Travel and Lodging: $1,455.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,439.05 |
| Travel and Lodging | $1,454.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Prodigy Surgical Distribution, INC. | $5,456.98 | 2019-2025 | |
| Stryker Corporation | $2,738.30 | 2019-2025 | Mako, Insignia, Salvation |
| Arthrex, INC. | $1,274.00 | 2019-2024 | |
| Smith+Nephew, INC. | $653.37 | 2019-2025 | Lens 4k, Bone Anchors With Arthroscopic Delivery System, Acufex |
| Zimmer Biomet Holdings, INC. | $139.45 | 2019-2022 | |
| Innovation Technologies INC | $58.94 | 2024 | Irrisept |
| Horizon Therapeutics Plc | $33.09 | 2021-2022 | |
| Ferring Pharmaceuticals INC. | $32.25 | 2021-2022 | |
| Dynasplint Systems INC. | $32.17 | 2019-2020 | |
| Vericel Corporation | $18.15 | 2023 | Maci |
| Djo, LLC | $17.85 | 2023 | Aircast, Donjoy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Cavagnaro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.